Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05345561 · ClinicalTrials.gov registry record
Study to Assess the Occurrence of HPA-1a Alloimmunization in Women With Higher Risk for Fetal and Neonatal Alloimmune Thrombocytopenia
A clinical trial of Fetal and Neonatal Alloimmune Thrombocytopenia, sponsored by Rallybio.
- Completed
- Registry status
- 14,390
- Enrollment target
- 20
- Study locations
NCT05345561 is a study of Fetal and Neonatal Alloimmune Thrombocytopenia that has completed, run by Rallybio. The registered enrollment target is 14,390 participants. The trial reports 20 study locations across 11 states.
The verdict
NCT05345561, a study of Fetal and Neonatal Alloimmune Thrombocytopenia, has completed, sponsored by Rallybio.
- COMPLETED
- Registry status
- 14,390 participants
- Enrollment target
- 20
- Study locations
Study Summary
A prospective, non-interventional, natural history study to assess the occurrence of higher FNAIT risk across a broad population of different racial and ethnic characteristics and the occurrence of HPA-1a alloimmunization in these women.
Conditions Studied
Interventions
- OTHER Clinical data collection
Study Locations (20)
New Jersey
- Cooper University Hospital - Camden
- Robert Wood Johnson Medical School - New Brunswick
- St. Peter's University Hospital - New Brunswick
- Rutgers New Jersey Medical School - Newark
New York
- Icahn School of Medicine at Mount Sinai - New York
- Columbia University Irving Medical Center - New York
- New York-Presbyterian-Queens - New York
- Weill Cornell Medicine-New York Presbyterian Hospital - New York
Texas
- Javara Inc. - Forest - Dallas
- The University of Texas Health Science Center at Houston - Houston
- Javara Research Inc. - Dallas - PPDS - Houston
Ohio
- Ohio State University Wexner Medical Center - Columbus
- Wright State Physicians Obstetrics & Gynecology - Dayton
Arizona
- New Horizons Clinical Trials, LLC - Chandler
California
- Zillan Clinical Research - Gardena - Gardena
Connecticut
- Yale University School of Medicine - New Haven
Florida
- University of Miami Miller School of Medicine - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14,390 participants |
| Start Date | 2022-03-14 |
| Est. Completion | 2025-10-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05345561
The ClinicalTrials.gov registry entry for NCT05345561 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 14,390 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rallybio, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Fetal and Neonatal Alloimmune Thrombocytopenia appearing as the primary indexed condition, and to 1 intervention - of which Clinical data collection is the first listed.
NCT05345561 reports 20 study locations spanning 11 distinct geographic areas - top geographies include New Jersey, New York, Texas.
Frequently Asked Questions
What is clinical trial NCT05345561 about?
NCT05345561 is a clinical study titled "Study to Assess the Occurrence of HPA-1a Alloimmunization in Women With Higher Risk for Fetal and Neonatal Alloimmune Thrombocytopenia". A prospective, non-interventional, natural history study to assess the occurrence of higher FNAIT risk across a broad population of different racial and ethnic characteristics and the occurrence of HPA-1a alloimmunization in these women.
What is the current status of trial NCT05345561?
This trial is currently completed. The enrollment target is 14,390 participants. The study started on 2022-03-14. Estimated completion is 2025-10-10.
What conditions does trial NCT05345561 study?
This clinical trial studies the following conditions: Fetal and Neonatal Alloimmune Thrombocytopenia.
What interventions are being tested in trial NCT05345561?
The interventions under investigation include: Clinical data collection (OTHER).
Who is sponsoring clinical trial NCT05345561?
This trial is sponsored by Rallybio, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05345561 being conducted?
This trial has 20 study locations across Arizona, California, Connecticut, Florida, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.